Demecolcine is a synthetic colchicine derivative and potent antimitotic agent known for its ability to disrupt microtubule polymerization, effectively arresting cell division at metaphase to synchronize… Read more
Demecolcine is a synthetic colchicine derivative and potent antimitotic agent known for its ability to disrupt microtubule polymerization, effectively arresting cell division at metaphase to synchronize tumor cells for enhanced radiotherapy and chemotherapy outcomes. Laboratories working with this compound require high-quality reference standards to ensure accurate identification and quantification during analytical testing. This category includes the parent active pharmaceutical ingredient, alongside related impurities such as isodemecolcine and specific metabolic derivatives like N-(2-mercaptoethyl) demecolcine. Additionally, stable isotope labelled compounds, including deuterated versions of demecolcine, serve as essential internal standards for mass spectrometry-based assays. These materials are critical for rigorous impurity profiling, method validation, and ongoing quality control, supporting the precise analysis of demecolcine and its derivatives in pharmaceutical research and development applications.